Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

NCT00937768 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma
Stage IIA Prostate Cancer
Stage IIB Prostate Cancer
Stage III Prostate Cancer
Stage IV Prostate Cancer

Interventions

DRUG: Goserelin Acetate
OTHER: Laboratory Biomarker Analysis
DRUG: Leuprolide Acetate
OTHER: Quality-of-Life Assessment

Sponsor

Mayo Clinic

Collaborators

[object Object]